Our DNA is a chemical alphabet of A, T, C and G, which together create the book of life. The mapped human genome has opened up incredible possibilities and scientists say we’re on the cusp of the golden age of genomic-based, personalized medicine.
How is the genetic roadmap empowering the medical community to find breakthrough treatments? Where is personalized medicine headed? What are the issues that we as a society should anticipate moving forward?
At a forum in New York, The Atlantic gathered key stakeholders in this conversation to discuss the future of the genomic era.
Watch full session videos
To view photos from this event, please visit our Facebook page
- Wednesday, April 26
- 8:30 a.m.WelcomeMargaret Low, President, AtlanticLIVE
- 8:35 a.m.State of Innovation and ResearchClaire Pomeroy, President, Albert and Mary Lasker Foundation
With Steve Clemons, Washington Editor at Large, The Atlantic
- 9:00 a.m. Dawn of the Genomic EraEdward Abrahams, President, Personalized Medicine Coalition
Karen Nelson, President, J. Craig Venter Institute
Aris Baras, Vice President, Regeneron Pharmaceuticals; Head, Regeneron Genetics Center
With James Hamblin, Senior Editor, The Atlantic
- 9:30 a.m.The Future VaccineRipley Ballou, VP, GSK Vaccines; Head, Slaoui Center for Vaccines Research, Rockville MD
Mark Feinberg, President and CEO, International AIDS Vaccine Initiative
With Steve Clemons, The Atlantic
- 10:00 a.m.The Business of Human Genomics* Produced by our underwriter PhRMA Robert J. Hugin, Executive Chairman, Celgene
With Meg Tirrell, Reporter, CNBC
- 10:10 a.m.Opportunities and Challenges AheadPaul Appelbaum, Director, Center for Research on Ethical, Legal and Social Implications of Psychiatric, Neurological, and Behavioral Genetics; Elizabeth K. Dollard Professor of Psychiatry, Medicine and Law at Columbia University
Ting Wu, Director and Co-Founder, Personal Genetics Education Project; Professor of Genetics, Harvard Medical School
Arthur Caplan, Director, Division of Medical Ethics, NYU School of Medicine; Drs. William F. and Virginia Connolly Mitty Professor of Bioethics
With James Hamblin, The Atlantic
- 10:45 a.m.Closing ThoughtsMargaret Low, AtlanticLIVE
Also in This Series
The Work Ahead: Business Confronts the COVID-19 Challenge
How will the pandemic change work?